Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin subunit alpha-1 is a large extracellular matrix glycoprotein that, along with beta and gamma chains, forms heterotrimeric laminin molecules essential for the structure and function of basement membranes in nearly all animal tissues. The laminin alpha-1 chain is crucial for organizing cell layers, mediating cell adhesion, migration, tissue development, and maintenance of extracellular matrix architecture. Mutations in *LAMA1* are linked to Poretti–Boltshauser syndrome, a rare developmental disorder. Laminins interact with high-affinity cell-surface receptors mediating tissue-specific functions and cellular behaviors, but are not classical drug targets[1][2][3][4][5][6][7].
Not applicable—no drugs with direct mechanisms of action targeting laminin subunit alpha chains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin subunit alpha-1 (LAMA1).